channel inhibition reduced tone at 20 and 80 mmHg, with the greatest effect at high pressure when the vessel is depolarized. In comparison, the effect of T-type Ca 2ϩ channel blockade on myogenic tone was more limited, with their greatest effect at low pressure where vessels are hyperpolarized. Blood flow modeling revealed that the vasomotor responses induced by T-type Ca 2ϩ blockade could alter arterial flow by ϳ20 -50%. Overall, our findings indicate that L-and T-type Ca 2ϩ channels are expressed in cerebral arterial smooth muscle and can be electrically isolated from one another. Both conductances contribute to myogenic tone, although their overall contribution is unequal. influx from the extracellular space (9). Voltage-gated Ca 2ϩ channels are the principal conductances that regulate extracellular Ca 2ϩ influx. These membrane channels are hetero-oligomeric complexes that comprise a pore-forming ␣ 1 -subunit and accessory proteins that influence gating characteristics and protein trafficking (24). The ␣ 1 -subunit is composed of four domains, each of which contain six transmembrane segments, a S4 voltage sensor, and a P loop that confers ion selectivity (21, 50). Molecular studies have identified three classes of ␣ 1 -subunits (Ca v 1-3), and within each category there are several subtypes. Ca v 1/Ca v 2 subunits display electrical properties characteristic of high voltage-activated Ca 2ϩ channels (i.e., L-, P/Q-, N-, and R types) (5). In contrast, Ca v 3 subunits encode for Ca 2ϩ channels activated by lower voltages (i.e., T type) (20, 34 channels was more limited and best observed at lower pressures in hyperpolarized vessels. Although the contribution of the channels to tone development is limited, computational
channels are expressed in rat cerebral arterial smooth muscle and determined their contribution to the myogenic response. mRNA analysis revealed that the ␣ 1-subunit of L-type (Cav1.2) and T-type (Ca v3.1 and Cav3.2) Ca 2ϩ channels are present in isolated smooth muscle cells. Western blot analysis subsequently confirmed protein expression in whole arteries. With the use of patch clamp electrophysiology, nifedipine-sensitive and -insensitive Ba 2ϩ currents were isolated and each were shown to retain electrical characteristics consistent with L-and T-type Ca 2ϩ channels. The nifedipine-insensitive Ba 2ϩ current was blocked by mibefradil, kurtoxin, and efonidpine, T-type Ca 2ϩ channel inhibitors. Pressure myography revealed that L-type Ca 2ϩ channel inhibition reduced tone at 20 and 80 mmHg, with the greatest effect at high pressure when the vessel is depolarized. In comparison, the effect of T-type Ca 2ϩ channel blockade on myogenic tone was more limited, with their greatest effect at low pressure where vessels are hyperpolarized. Blood flow modeling revealed that the vasomotor responses induced by T-type Ca 2ϩ blockade could alter arterial flow by ϳ20 -50%. Overall, our findings indicate that L-and T-type Ca 2ϩ channels are expressed in cerebral arterial smooth muscle and can be electrically isolated from one another. Both conductances contribute to myogenic tone, although their overall contribution is unequal.
voltage-gated Ca 2ϩ channels; Ca 2ϩ regulation; myogenic tone; vascular smooth muscle cells ARTERIAL SMOOTH MUSCLE CELLS actively respond to vasoactive stimuli, altering arterial diameter and tissue blood flow. Changes in vessel tone are the result of myosin light chain 20 phosphorylation, a process dynamically controlled by Ca 2ϩ influx from the extracellular space (9) . Voltage-gated Ca 2ϩ channels are the principal conductances that regulate extracellular Ca 2ϩ influx. These membrane channels are hetero-oligomeric complexes that comprise a pore-forming ␣ 1 -subunit and accessory proteins that influence gating characteristics and protein trafficking (24) . The ␣ 1 -subunit is composed of four domains, each of which contain six transmembrane segments, a S4 voltage sensor, and a P loop that confers ion selectivity (21, 50) . Molecular studies have identified three classes of ␣ 1 -subunits (Ca v 1-3), and within each category there are several subtypes. Ca v 1/Ca v 2 subunits display electrical properties characteristic of high voltage-activated Ca 2ϩ channels (i.e., L-, P/Q-, N-, and R types) (5) . In contrast, Ca v 3 subunits encode for Ca 2ϩ channels activated by lower voltages (i.e., T type) (20, 34) .
Ca v 1.2 is a key pore-forming subunit of L-type Ca 2ϩ channels in cerebral arterial smooth muscle. There are at least three splice variants, and, upon depolarization, its graded activation plays a central role in setting cytosolic [Ca 2ϩ ] (7, 32) . Although L-type Ca 2ϩ channel activation is important for tone development, channel blockade does not eliminate all arterial responsiveness. Case-in-point is the work of Mufti et al. (39) who showed that ϳ20% of the myogenic response was insensitive to diltiazem, an L-type Ca 2ϩ channel inhibitor. Such observations have fostered the view that there are additional Ca 2ϩ flux pathways that help set cytosolic [Ca 2ϩ ] and thus the level of myogenic tone (10, 25, 51) . In this context, recent studies have noted that Ca v 3.1 and Ca v 3.2, the ␣ 1 -subunit of T-type Ca 2ϩ channels, are present in resistance arteries (23, 41) . T-type Ca 2ϩ channels activate ϳ10 -15 mV negative to L-type Ca 2ϩ channels and thus are positioned to regulate Ca 2ϩ influx at more hyperpolarized potentials (43) . Although Ca 2ϩ influx through T-type Ca 2ϩ channels could facilitate myogenic tone development, experimental findings are limited and incomplete (40) .
The present study determined which voltage-gated Ca 2ϩ channels are expressed in rat cerebral arteries and what role they play in myogenic tone development. To meet this objective, we combined the experimental strengths of molecular biology, patch clamp electrophysiology, vessel myography, and computational modeling. Our RT-PCR and Western blot analysis revealed that the ␣ 1 -subunits of Ca v 1.2 (L type) and Ca v 3.1/3.2 (T type) were expressed at the mRNA and protein level in isolated smooth muscle cells and whole cerebral arteries, respectively. Consistent with these observations, patch clamp electrophysiology revealed the presence of two distinct Ba 2ϩ currents, with electrical and pharmacological fingerprints characteristic of L-or T-type Ca 2ϩ channels. Functionally, L-type Ca 2ϩ channel inhibition attenuated myogenic tone development, particularly at higher pressures where arteries are depolarized. In comparison, the contribution of T-type Ca 2ϩ channels was more limited and best observed at lower pressures in hyperpolarized vessels. Although the contribution of the channels to tone development is limited, computational modeling indicates that T-type Ca 2ϩ channel activity is sufficient to alter resting blood flow by 20 -50%. In closing, our findings demonstrate that ␣ 1 -subunits of L-and T-type Ca 2ϩ channels are both expressed in cerebral arterial smooth muscle and that they encode for a distinct voltage-dependent conductance. Our data further reveal that each current contributes, albeit unequally, to the maintenance of myogenic tone, a key physiological response in the cerebral circulation.
METHODS
Animal procedures. Animal procedures were approved by the Animal Care and Use Committee at the University of Calgary. Briefly, female Sprague-Dawley rats (10 -12 wk of age) were euthanized via carbon dioxide asphyxiation. The brain was carefully removed and placed in cold phosphate-buffered (pH 7.4) saline solution containing (in mM) 138 NaCl, 3 KCl, 10 Na2HPO4, 2 NaH2PO4, 5 glucose, 0.1 CaCl2, and 0.1 MgSO4. Middle and posterior cerebral arteries were carefully dissected out of surrounding tissue and cut into 2-to 3-mm segments.
Vessel myography. Arterial segments were mounted in a customized arteriograph and superfused with warm (37°C) physiological salt solution (PSS; pH 7.4; 21% O2, 5% CO2, balance N2) containing (in mM) 119 NaCl, 4.7 KCl, 20 NaHCO3, 1.1 KH2PO4, 1.2 MgSO4, 1.6 CaCl2, and 10 glucose (29, 52) . To limit the tonic dilatory influence of the endothelium on myogenic tone development (26, 29) , these cells were removed by passing air bubbles through the vessel lumen (1 to 2 min); successful removal was confirmed by the loss of bradykinin-induced dilation. Arteries were equilibrated for 30 min at 15 mmHg and contractile responsiveness assessed by briefly exposing (ϳ10 s) tissue to 60 mM KCl. After equilibration, intravascular pressure was increased incrementally from 15 to 20, or 80 mmHg. Vessels were then exposed to one of three experimental protocols: 1) nifedipine (50 and 300 nM) ϩ mibefradil (1 and 5 M), 2) nifedipine ϩ kurtoxin (1 M), or 3) nifedipine ϩ efonidipine (3 M). Each protocol was followed by the addition of a Ca 2ϩ free physiological salt solution (0 externally added Ca 2ϩ ϩ 2 mM EGTA). In one additional set of experiments, arterial tone was sequentially measured at 20, 40, 60, 80, and 100 mmHg under control conditions and in the presence of nifedipine (300 nM) Ϯ mibefradil (5 M). Arterial diameter was monitored using an automated edge detection system (IonOptix).
Isolation of arterial smooth muscle cells. Smooth muscle cells from middle and posterior cerebral arteries were enzymatically isolated as described previously (33, 50) . Briefly, arterial segments were placed in an isolation medium (37°C, 10 min) containing (in mM) 60 NaCl, 80 Na ϩ glutamate, 5 KCl, 2 MgCl2, 10 glucose, and 10 HEPES with 1 mg/ml albumin (pH 7.4). Vessels were then exposed to a two-step digestion process that involved: 1) a 15-min incubation in isolation media (37°C) containing 0.6 mg/ml papain and 1.8 mg/ml dithioerythritol and 2) a 15-min incubation in isolation medium containing 100 m Ca 2ϩ , 0.7 mg/ml type F collagenase and 0.4 mg/ml type H collagenase. After treatment, tissues were washed repeatedly with ice-cold isolation medium and triturated with a fire-polished pipette. Liberated cells were stored in ice-cold isolation medium for use the same day.
PCR analysis. Smooth muscle cells (ϳ200) isolated from middle and posterior cerebral arteries were placed in RNase-and DNase-free collection tubes. Total RNA was extracted (RNeasy mini kit with DNAase treatment; Qiagen, Valencia, CA) and first-strand cDNA synthesized using the Sensi-script RT kit (Qiagen) with oligo d(T) primer. Subsequently, 2 l of each first-strand cDNA reaction was used as template in a PCR reaction containing 1.5 mM MgCl 2; 0.25 M forward and reverse primers; 0.2 mM deoxynucleotide triphosphates; and 2.5 M recombinant Taq DNA polymerase. The PCR reaction protocol includes a denaturation step at 92°C for 5 min; 45 cycles of 92°C for 45 s, 55°C for 60 s, and 72°C for 2 min; and a final extension step at 72°C for 5 min. Forward and reverse primers specific were as follows: Ca V1.1 (400 bp), (forward) 5=-TGCTGATCGTCATGCTCTTC-3=, (reverse) 5=-ATGGC-CTTGAACTCATCCAG-3; Ca V1.2 (400 bp), (forward) 5=-GC-CTCTTCACGGTGGAG-3=, (reverse) 5=-TCCCAATCACTGCA-TAGATAA-3=; Ca V1.3 (399 bp), (forward) 5=-TCCGAAGAGCCTG-CATTAGT-3=, (reverse) 5=-GCGGTCTTAACACTCGGAAG-3=; Ca V1.4 (500 bp), (forward) 5=-GCAAAGTGGCTCTTCAGGAC-3=, (reverse) 5=-GTTGAGGGGAACATTCATGG-3=; Ca V2.1 (501 bp), (forward) 5=-CTGCTTTGAAGAGGGGACAG-3=, (reverse) 5=-CGAA-GAGCTCCATCAAAAGG-3=; Ca V2.2 (504 bp), (forward) 5=-TGTTCAGCAAGTGGCTTTTG-3=, (reverse) 5=-TTTCAGGGG-GAACAGACAAC-3=; Ca V2.3 (502 bp), (forward) 5=-TCCTGCATGA-CAACCAACAT-3=, (reverse) 5=-GGTCTCGGAAGTACGATCCA-3=; Ca V3.1 (501 bp), (forward) 5=-TCTTCCAGGACAGGTGGAAC-3=, (reverse) 5=-TCAGCACGAAGGACACAAAG-3=; Ca V3.2 (402 bp), (forward) 5=-AGTTTCCTCTTTGGGGGCTA-3=, (reverse) 5=-CAGG-AAAACCCAAACCTGAA-3=; Ca V3.3 (501 bp), (forward) 5-CCCTG-GAGATGATCCTGAAA-3, (reverse) 5-AGTTGCCAAAGGTCAT-GAGG-3; ␤-actin (130 bp), (forward) 5=-TATGAGGGTTAC-GCGCTCCC-3=, (reverse) 5=-ACGCTCGGTCAGGATCTTCA-3=. After electrophoresis on a 1.5% agarose gel, the PCR products were excised, extracted, and purified. Sequencing was performed at the University of Calgary DNA facility. Smooth muscle cell samples were screened for template and endothelial cell contamination, as previously described (53) .
Western blotting. Cortex or cerebral arterial segments from two rat brains were placed in 100 l of lysis buffer (pH 7.4) containing (in mM) 150 NaCl, 1 CaCl 2, 1 MgCl2, 10 HEPES, 0.5% Tween, and 10% mammalian protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Samples were mechanically disrupted, exposed to three freezethaw cycles, and then centrifuged (10 min; 13,000 rpm). Supernatant was placed in a clean tube, assayed for total protein, and stored at Ϫ20°C for up to 1 wk. Samples were prepared for electrophoresis by placing 15 l of supernatant in 5 l of 4ϫ sample buffer, and 2 l of DTT. After heating (10 min; 90°C) was completed, 20 mg of protein were loaded to run on a 5.6% polyacrylamide gel. Protein was transferred to a polyvinylidene difluoride membrane (PVDF), blocked for 2 h (5% nonfat milk in Tris-buffered saline), and incubated overnight (4°C) with a primary antibody [Cav1.2 (1:200), Cav3.1 (1:200), Cav3.2 (1:200); Alomone Laboratories], diluted in milk-Trisbuffered saline. The polyvinylidene difluoride membrane was subsequently washed and incubated with a horseradish peroxidase-conjugated secondary antibody (1:1,000; Jackson Laboratories) diluted in milk-Tris-buffered saline (1 h; 20 -22°C). Washing was repeated and the blot developed using chemiluminescent substrate (Pierce Biochemicals). Emitted light was detected with a chemiluminescence image analyzer and analyzed with Multi Gauge v3.0 software (Fujifilm).
Electrophysiology. Conventional patch-clamp electrophysiology was used to measure whole-cell currents in isolated smooth muscle cells. Briefly, recording electrodes (pipette resistance, 4 -7 M⍀) were fashioned from borosilicate glass, covered in sticky wax to reduce capacitance, and backfilled with pipette solution containing (in mm) 135 CsCl, 2.5 Mg-ATP, 10 HEPES, and 10 EGTA (pH 7.2). This pipette was then gently lowered onto a cell and negative pressure applied to rupture the membrane. With series resistance Ͻ10 M⍀ and input resistance Ͼ10 G⍀, cells were then voltage clamped (Ϫ60 mV) and equilibrated for 5 min in a bath solution containing (in mm) 110 NaCl 110, 135 CsCl, 4 TEA-Cl, 1.2 MgCl2, 10 BaCl2, 10 HEPES, and 10 glucose (pH 7.4). The voltage protocol consisted of a prepulse to Ϫ90 or Ϫ60 mV (200 ms) followed by a series of voltage steps from Ϫ80 mV to ϩ40 mV (200 -300 ms, 10-mV increments). This protocol was run under control conditions and in the presence of nifedipine (300 nM) Ϯ mibefradil (5 M), kurtoxin (5 M), and efondipine (3 M). Whole-cell currents were recorded on an Axopatch 200B amplifier (Axon Instruments), filtered at 1 kHz, digitized at 5 kHz, and stored on a computer for subsequent analysis with Clampfit 10.2 software. Cell capacitance ranged between 14 and 18 pF and was measured with the cancellation circuitry in the voltage-clamp amplifier. A 1-m NaCl-agar salt bridge between the reference electrode and the bath solution was used to minimize offset potentials (Ͻ2 mV). All experiments were performed at room temperature (20 -22°C) .
Computational blood flow modeling. A previously developed theoretical model (15, 46, 47) was used to calculate two-phase [red blood cell (RBC) and plasma] steady-state flow in the arteriolar networks considered. This model implements conservation of blood and RBC volume flow at each node joining three vessels and includes known blood rheology, specifically, the Fahraeus and Fahraeus-Lindqvist effects in unbranched segments and phase separation at diverging bifurcations. Besides geometric information, the model requires specification of boundary conditions in the form of hematocrit at the inlet segment (upstream end of the 1st-order posterior cerebral artery) and pressure changes between the inlet node and outlet nodes (downstream ends of the 3rd-order posterior arteries). All flow simulations used an inlet hematocrit of 0.4, and inlet and outlet pressures of 75 mmHg and 50 mmHg, respectively. Arterial diameter/length values were set according to functional measurements from posterior cerebral vessels pressurized to 60 mmHg. Values were as follows: 1st order: 164 m diameter, 3.6 mm length; 2nd order: 150 m diameter, 3.5 mm length; and 3rd order: 125 m diameter, 1.1 mm length.
Statistical analysis. Data are expressed as means Ϯ SE, and n indicates the number of vessels or cells. No more than two experiments were performed on vessels from a given animal. Where appropriate, paired and unpaired t-tests were performed to compare the effects of a given condition/treatment on arterial diameter, or wholecell current (see figure legends for specific details). P values Յ0.05 were considered statistically significant.
Solutions and chemicals. All buffers, chemicals, and reagents were purchased from Sigma-Aldrich unless otherwise stated.
RESULTS

Ca
2ϩ channel ␣ 1 -subunit expression in middle and posterior cerebral arteries. This study began with an mRNA characterization of Ca V ␣ 1 -subunit expression in whole cerebral arteries and isolated smooth muscle cells. Primers were designed against rat sequences and efficacy confirmed by screening a range of appropriate control tissues. All ␣ 1 -subunit products were sequenced and their identity confirmed by mass spectroscopy. With the use of whole cerebral arteries, this study subsequently confirmed that ␣ 1 -subunits for high (Ca v 1.1, Ca v 1.2, Ca v 1.3, and Ca v 2.2) and low (Ca v 3.1, Ca v 3.2, and Ca v 3.3) voltage-activated Ca 2ϩ channels were observable at the mRNA level (Fig. 1A ). This expression profile was reduced to Ca v 1.2, Ca v 3.1, and Ca v 3.2 in isolated smooth muscle cells (Fig. 1B) . Note that isolated smooth muscle cells were prescreened for endothelial contamination by using primers against ET-1. With the use of the mRNA observations as a guide, Western blot analysis was subsequently performed to confirm protein expression. With the use of brain as the positive control, this study confirmed that the ␣ 1 -subunits of L-type (Ca v 1.2) and T-type (Ca v 3.1 and Ca v 3.2) Ca 2ϩ channels ( Fig. 2 ) were present at the protein level in whole cerebral arteries.
Whole-cell Ba 2ϩ currents in cerebral arterial smooth muscle cells. Building on the preceding observations, we next ascertained whether whole-cell patch clamp electrophysiology could delineate L-and T-type Ca 2ϩ channels from one another. Cerebral arterial smooth muscle cells were enzymatically isolated, and whole-cell currents were monitored in the presence of 10 mM Ba 2ϩ to accentuate charge flow through L-and T-type Ca 2ϩ channels.
Stepping from a prepulse of Ϫ90 mV, voltage protocols first revealed an inward Ba 2ϩ current that activated below at Ϫ30 mV and peaked at ϩ10 mV (Fig. 3) . If the prepulse was changed to Ϫ60 mV to facilitate T-type Ca 2ϩ channel inactivation whole-cell current decreased by ϳ10% at ϩ10 and ϩ20 mV. Experiments next observed that nifedipine, applied at concentrations approximately five-to 30-fold higher than the IC 50 value for the smooth muscle variant of Ca V 1.2 (22) , blocked ϳ75% of the whole-cell Ba 2ϩ current (Fig. 4, A  and B) . Plots in Fig. 4C highlight that the current-voltage relationship of the nifedipine-insensitive current is leftward shifted in relation to the nifedipine-sensitive component. Note that the preceding nifedipine concentrations are predicted, based on previous work to block Ͼ98% of all L-type Ca 2ϩ channels in this vascular preparation (37) . Higher micromolar concentrations were avoided since they interfere with Ca V 3.1 and Ca V 3.2 channels (1, 31) .
With expansion on these findings, further work was performed to determine whether the nifedipine-insensitive current reflected T-type Ca 2ϩ channel activation. The experimental approach consisted of two elements, the first centered on whether the nifedipine-insensitive component was blocked by T-type Ca 2ϩ channel inhibitors including mibefradil, efonidipine, and kurtoxin. These agents were applied at concentrations 10-to 20-fold above the IC 50 value for Ca V 3.1 and Ca V 3.2 and should block Ͼ95% of all T-type Ca 2ϩ channels (14, 19, 35, 38) . The second involved an electrical analysis where the time constants of activation/inactivation () were calculated for the nifedipine-and the T-type Ca 2ϩ channel inhibitor-sensitive components. Figure 5 , A and B, highlights that the nifedipineinsensitive component of the whole-cell Ba 2ϩ current was blocked by 5 M mibefradil, a T-type Ca 2ϩ channel blocker. The time constants for activation/inactivation, calculated at ϩ10 to ϩ20 mV, were faster for the mibefradil-than the nifedipine-sensitive component, a finding consistent with the former agent blocking activated T-type Ca 2ϩ channels ( 5C). The nifedipine-insensitive component was abolished by other T-type Ca 2ϩ channel blockers including 1 M kurtoxin (Fig. 6, A and B) or 3 M efonidipine (Fig. 7, A and B) . The activation/inactivation time constants were also faster for the kurtoxin/efondipine-sensitive rather than the nifedipine-sensitive component of the whole-cell Ba 2ϩ current. Reverse-order experiments were not performed since these T-type Ca 2ϩ channel inhibitors will block L-type Ca 2ϩ channels when applied at micromolar concentrations (22) . Note, in these longer recordings, a small linear current characteristic of leak was at times evident after the addition of T-type Ca 2ϩ blockers. Ca 2ϩ channels blockers and myogenic tone. Having determined that L-and T-type Ca 2ϩ channels are electrically present in cerebral arterial smooth muscle cells, we next determined their role in myogenic tone development. The approach consisted of the sequential application of L-and then T-type Ca 2ϩ channel blockers to middle/posterior cerebral arteries pressurized to 20 or 80 mmHg. At 20 mmHg, arterial membrane potential will rest near Ϫ55 mV, whereas at 80 mmHg, tissues will depolarize to Ϫ35 mV (30, 49) . At these different voltages, Ca 2ϩ influx through L-and T-type Ca 2ϩ channels should vary along with their relative contribution to the myogenic response. At 20 mmHg, cerebral arteries displayed 35 Ϯ 4 m of tone (Fig. 8, A and C) . The addition of nifedipine to the superfusate modestly attenuated tone development as did mibefradil, a T-type Ca 2ϩ channel blocker. Pressurizing middle or posterior cerebral arteries to 80 mmHg augmented resting tone to 90 Ϯ 6 m (Fig. 8, B and D) . In this depolarized and constricted state, nifedipine application had a disproportionally greater effect on myogenic tone development than mibefradil. Figure 8E highlights, by using both absolute and relative representations, that L-type Ca 2ϩ channel activation plays an increasing role to tone development with pressurization. In contrast, the T-type Ca 2ϩ channel component did not substantively change in absolute terms with vessel pressurization; it did, however, significantly decrease when expressed relative to the maximal response. A similar pattern was observed when the preceding experiment was repeated with efondipine ( Fig. 9) or kurtoxin (Fig. 10) , two structurally dissimilar T-type Ca 2ϩ channel blockers (14, 19) . The relative importance of L-and T-type Ca 2ϩ channels was better revealed in Fig. 11 where myogenic tone was monitored over a more complete pressure range (20 -100 mmHg) before and after the sequential addition of nifedipine and mibefradil. As above, the functional contribution of L-type Ca 2ϩ channels to arterial tone increases with pressurization where that of T-type Ca 2ϩ channels decreased.
Although T-type Ca 2ϩ channel blockade elicits only limited vasomotor responses, these alterations are likely sufficient to influence blood flow control as evident through blood flow modeling (Fig. 12) . In detail, this computational work revealed that a 5-15% change in resting diameter (comparable with that induced by T-type Ca 2ϩ channel blockade at 60 mmHg) elicited a 20 -50% change in network perfusion. With these simulations, we assume that T-type Ca 2ϩ channel expression is constant among the three vessel orders.
DISCUSSION
In this study of the rat cerebral circulation, we determined which voltage-gated Ca 2ϩ channels are expressed and whether they are important to myogenic tone development. In this regard, we used 1) molecular/biochemical approaches to determine which ␣ 1 -subunits were present, 2) patch clamp electrophysiology to characterize Ca 2ϩ channel properties, and 3) vessel myography to ascertain function. An mRNA assessment revealed that the ␣ 1 -subunit of L-type (Ca V ible into a nifedipine-sensitive (L-type) and -insensitive component. The latter was blocked by mibefradil, kurtoxin, and efonidipine and displayed activation/inactivation properties consistent with T-type Ca 2ϩ channels. Functional experiments further revealed that L-type Ca 2ϩ channels are principally responsible for driving myogenic tone, although a limited role for T-type Ca 2ϩ channels is evident in hyperpolarized vessels. Blood flow modeling indicates that T-type Ca 2ϩ channel modulation could alter blood flow through the posterior cerebral circulation by ϳ20 -50%.
Background. Voltage-gated Ca 2ϩ channels are expressed in a diverse range of excitable and nonexcitable tissue (6) . Structurally, the pore-forming ␣ 1 -subunit comprises four membrane-spanning domains (I-IV) linked together in a single polypeptide chain. Each domain contains six transmembrane segments plus a P loop that dips incompletely into the pore to confer selectivity (11, 18) . Molecularly, voltage-gated Ca 2ϩ channels are categorized according to ␣ 1 -subunit expression, and there is, at present, three main classifications including Ca V 1.x (L-type), Ca V 2.x (P/Q-, N-, and R types), and Ca V 3.x (T type). Ca V 1.x and Ca V 2.x encode for Ca 2ϩ channels that are more active at depolarized voltages compared with the low voltage-activated Ca V 3.x subunits (2, 16) . In vascular smooth muscle, Ca V 1.2 principally controls steady Ca 2ϩ entry, myosin light chain phosphorylation, and tone development (17, 27) . Although important to tone development, recent studies have suggested that this ␣ 1 -subunit is not singularly expressed in arterial smooth muscle (4, 28, 41, 44) . For example, immunohistochemical observations have suggested that ␣ 1 -subunits of T-type Ca 2ϩ channels are present in the renal, mesenteric, and cerebral circulation (4, 13, 40) . Supporting electrophysiological findings are sparse, although selected studies have shown that a nifedipine-insensitive Ba 2ϩ current with properties reminiscent of T-type Ca 2ϩ channels can be isolated in arterial smooth muscle (40, 41) . At present, it is not clear what role T-type Ca 2ϩ channels play in arterial tone development. Past functional findings have been decidedly mixed with only a small number indicating a limited to prominent contribution, depending on the vascular bed and stimulus (4, 16, 28, 45) . Others, however, have argued that T-type Ca 2ϩ channels have no role in the contractile process and that their principal function centers on cell cycle regulation and proliferation (42, 43, 48).
Molecular and electrical characterization. This study began by examining which voltage-gated Ca
2ϩ channels are present in cerebral arterial smooth muscle. Work was initiated at a molecular level with a PCR analysis of whole arteries and isolated smooth muscle cells from rat middle/posterior cerebral arteries. Consistent with past findings (4), multiple ␣ 1 -subunits were observed in whole arteries including Ca V 1.1-1.3, Ca V 2.2, and Ca V 3.1-3.3 (Fig. 1) . The breadth of the mRNA profile was expected since whole arteries comprise three major cells types (smooth muscle, endothelium, and perivascular nerves), all of which can express Ca V ␣ 1 -subunits (8) . Limiting mRNA analysis to isolated smooth muscle cells, a first for the cerebral circulation, reduced the expression pattern to Ca V 1.2 (L-type) and Ca V 3.1/3.2 (T-type). Western blot analysis subsequently confirmed that each ␣ 1 -subunit was expressed at the protein level in cerebral arteries (Fig. 2) . Although this study did not pursue an immunohistochemical analysis, Kuo et al. (28) has shown that all three ␣ 1 -subunits are indeed present in rat cerebral arterial smooth muscle (28) .
With molecular/biochemical evidence of L-and T-type Ca 2ϩ channels expressed in cerebral arterial smooth muscle, we next used patch clamp electrophysiology to functionally isolate and identify the two general conductances. Like past studies, experimentation began by monitoring Ba 2ϩ currents in cells held at Ϫ90 or Ϫ60 mV, the concept being that the hyperpolarized holding potential would relieve voltage-dependent inactivation of T-type Ca 2ϩ channels and thus augment whole-cell current (40, 41) . Consistent with this perspective, we found that shifting the holding potential to more negative voltages enhanced inward Ba 2ϩ currents by 10% (Fig. 3) . This subtle but significant increase was observed despite the fact that millimolar Ba 2ϩ elicits a rightward shift in the voltagedependent properties of T-type Ca 2ϩ channels, reducing the overall efficacy of the protocol (43) . Building on these observations, we next monitored inward Ba 2ϩ currents in the presence and absence of nifedipine to determine whether a dihyropyridine-insensitive current with T-type Ca 2ϩ channel properties could be functionally isolated (Fig. 4) . Nifedipine blocks L-type Ca 2ϩ channels in a state-dependent manner by binding to inactivated pores (11, 32) . Concentrations were set five-to 30-fold above than the IC 50 for the smooth muscle splice variants of Ca V 1.2 (22) and below levels that interfere with T-type Ca 2ϩ channels (1, 31) . At levels that should block Ͼ98% of all L-type Ca 2ϩ channels, whole-cell inward current decreased by ϳ75%, a finding in agreement with Nikitina et al. (41) in dog basilar artery and Kuo et al. (28) in rat cerebral circulation. The residual nifedipine-insensitive current displayed a leftward shifted current-voltage relationship characteristic of T-type Ca 2ϩ channels (20, 43) . A more detailed examination of the nifedipine-insensitive current followed with experiments monitoring the effects of T-type Ca 2ϩ channel blockers and characterizing key electrical properties. In regards to the former, Figs. 5-7 show that mibefradil, efondipine, and kurtoxin effectively blocked the nifedipine-insensitive Ba 2ϩ current. As to the latter, an analysis of mibefradil/efondipine/ kurtoxin difference currents revealed that the activation/inactivation time constants were more rapid than the nifedipinesensitive current and corresponded well with published values for Ca V 3.1/3.2 and Ca V 1.2, respectively (28, 43) . Overall, the preceding patch clamp observations indicate L-and T-type Ca 2ϩ channels are not only electrically present in cerebral arterial smooth muscle but divisible from one another.
T-type Ca 2ϩ channels and myogenic tone. When T-type Ca 2ϩ channels are recorded in solutions containing physiological concentrations of Ca 2ϩ , they display a V 0.5 for steady state activation/inactivation that is 10 -15 mV negative to Ca V 1.2 (41, 43). As such, there will be a subsequent leftward shift in the window current (28, 40, 41, 43) . From this knowledge, it is logical to predict that the contribution of T-type Ca 2ϩ channels to tone development should be more prominent at hyperpolarized potentials. To test this hypothesis, this study examined myogenic tone development and examined what effect the sequential addition of L-and then T-type Ca 2ϩ channel blockers might elicit on cerebral arteries pressurized to 20 or 80 mmHg. It was theorized that at 20 mmHg, vessels would reside in a hyperpolarized state (ϳϪ55 mV) and that T-type Ca tivation properties (43) . In contrast, at 80 mmHg, cerebral arteries would be more depolarized (ϳϪ35 mV) and L-type Ca 2ϩ channel activity would be predicted to dominate over T type (3, 27) . Findings in Figs. 8 -10 clearly illustrate that T-type Ca 2ϩ channel blockers, such as mibefradil, kurtoxin, and efonidipine, do impair the nifedipine-insensitive component of the myogenic response. When expressed on a relative scale, the contribution of T-type Ca 2ϩ channels was greatest at low intravascular pressures where the vessel is hyperpolarized (Ϫ55 mV) (28, 41, 43 ). As expected, the functional signifi- cance of L-type Ca 2ϩ channels increased with pressurization, a finding consistent with the literature and the electrophysiological properties of high voltage-activated Ca 2ϩ channels (3, 27) . The inverse contribution of L-and T-type Ca 2ϩ channels to myogenic tone development is better observed in Fig. 11 when cerebral arteries were stepped sequentially from 20 to 100 mmHg. Although previous studies have attempted similar measurements (16, 28, 41), this study is the first to show clear evidence that T-type Ca 2ϩ channels contribute to myogenic tone development in a manner consistent with their voltagedependent properties (43) .
In regard to the preceding findings and their interpretation, this study implicitly assumed that T-type Ca 2ϩ channels operate as a general influx pathway, providing a portion of the extracellular Ca 2ϩ required for contractile activation. Although reasoned, it is plausible that T-type Ca 2ϩ channels might also facilitate arterial tone through alternative mechanisms. For example, Ca 2ϩ flux via Ca V 3.1 or Ca V 3.2 channels might be sufficient to activate a Ca 2ϩ -dependent inward current such as TRPM4, a transient receptor potential channel that contributes to pressure-induced depolarization (12) . They might also initiate and/or maintain Ca 2ϩ waves, asynchronous events dependent on Ca 2ϩ release from the sarcoplasmic reticulum (4, 36). Like T-type Ca 2ϩ channels, these events are more important at setting myogenic tone at hyperpolarized rather than depolarized voltages (39).
Implications to blood flow control. The observations in Figs. 8 -11 highlight that T-type Ca 2ϩ channels contribute to myogenic tone development in the cerebral circulation. Although their overall role is limited, it would be imprudent to overlook their impact on tissue perfusion since flow is proportionally related to blood pressure and vessel radius raised to the 4th power. To better illustrate what impact T-type Ca 2ϩ channels could have on tissue perfusion, blood flow simulations were performed on a network structure that mimicked the proximal aspects of the posterior cerebral circulation (Fig. 12) . This network structure consisted of seven segments whose diameter and length were set according to measurements on 1st-to 3rd-order posterior cerebral arteries pressurized to 60 mmHg. Blood and RBC volume flow were conserved, whereas hematocrit along with inlet and outlet pressure were set to 0.4, 75, and 50 mmHg, respectively. With this model, we observed that 5-15% changes in resting arterial diameter, generally akin to dilatory responses induced by T-type Ca 2ϩ channel inhibition A: a computational model (15, 46, 47) was used to calculate 2-phase steady-state flow through an arterial network consisting of 7 arterial branches whose diameter/length approximates the posterior cerebral arterial network diverging off the Circle of Willis. This model implements conservation of blood and red blood cell volume flow at each node joining vessel segments and includes known blood rheology. In addition to geometric information, this model required specification of boundary conditions in the form of hematocrit (0.4) and pressure changes between the inlet (75 mmHg) and outlet (50 mmHg) segments. B and C: impact of a 5-15% change in vessel diameter on network blood flow.
at 60 mmHg, augmented network perfusion by ϳ20 -50%. From such findings, we deduce that T-type Ca 2ϩ modulation could be functionally important and have a measurable impact on tissue perfusion.
Summary. This study demonstrated that multiple voltagegated Ca 2ϩ channels are present in the rat cerebral circulation. More specifically, molecular and electrophysiological approaches revealed that both L-type (Ca V 1.2) and T-type (Ca V 3.1 and Ca V 3.2) Ca 2ϩ channels are expressed and electrically discernible in smooth muscle cells from middle/posterior cerebral arteries. Functional analysis revealed that T-type Ca 2ϩ channels contribute to the genesis of the myogenic response. Their functional significance was more evident at low intravascular pressure where the hyperpolarized state of the vessels would optimize steady-state Ca 2ϩ influx, given the voltagedependent properties of the channel (43) . Although the overall contribution of channels to tone control is modest, blood flow modeling indicates that T-type Ca 2ϩ channel modulation could alter resting blood flow by as much as 50%. 
